Ethylene Glycol

Ethylene Glycol

SCHEMBL5469827

CCC(CC)(C(=O)O)C(=O)O.OCCO

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.35
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
THRB P10828 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 2/20 0.33
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
CYP4F2 P78329 1/20 0.30
CYP4A11 Q02928 1/20 0.30
GRM2 Q14416 1/20 0.30
GRM3 Q14832 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51201 0.91 FFAR3 (0.41) FFAR3ALDH1A1MEN1CYP1A2THRB
Alcohol SCHEMBL5149703 0.88 ALDH1A1 (0.35) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL4382923 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL4882973 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL28746064 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL9489101 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL17818653 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL104624 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
SCHEMBL3673385 0.88 ALDH1A1 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB
Hydrochloric Acid SCHEMBL8053454 0.88 FFAR3 (0.39) FFAR3ALDH1A1MEN1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249862-A1 Process for the Production of Polyisocyanate/Polysilicic Acid Based Resins with Widely Variable Processability and Setting Periods CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249862-A1 Process for the Production of Polyisocyanate/Polysilicic Acid Based Resins with Widely Variable Processability and Setting Periods ME1, PICALM, CA6 FFAR3 2655/4885ALDH1A1 2743/4885MEN1 4540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.